Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in Hercules Capital, Inc. $HTGC

Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Hercules Capital, Inc. (NYSE:HTGC) by 15.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,018,759 shares of the financial services provider’s stock after acquiring an additional 133,813 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Hercules Capital were worth $19,173,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of HTGC. Integrated Wealth Concepts LLC grew its position in Hercules Capital by 5.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 17,241 shares of the financial services provider’s stock valued at $331,000 after acquiring an additional 959 shares during the last quarter. Empowered Funds LLC lifted its position in shares of Hercules Capital by 85.9% during the first quarter. Empowered Funds LLC now owns 22,854 shares of the financial services provider’s stock worth $439,000 after purchasing an additional 10,559 shares during the last quarter. Focus Partners Wealth boosted its stake in shares of Hercules Capital by 26.0% during the first quarter. Focus Partners Wealth now owns 15,747 shares of the financial services provider’s stock valued at $302,000 after purchasing an additional 3,250 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Hercules Capital by 81.8% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 4,780 shares of the financial services provider’s stock valued at $87,000 after purchasing an additional 2,151 shares during the period. Finally, Invesco Ltd. grew its holdings in shares of Hercules Capital by 1.6% in the second quarter. Invesco Ltd. now owns 78,951 shares of the financial services provider’s stock worth $1,443,000 after purchasing an additional 1,252 shares during the last quarter. Hedge funds and other institutional investors own 19.69% of the company’s stock.

Insiders Place Their Bets

In other Hercules Capital news, Director Thomas J. Fallon purchased 20,000 shares of the stock in a transaction dated Friday, February 27th. The stock was purchased at an average price of $14.20 per share, with a total value of $284,000.00. Following the transaction, the director owned 150,369 shares of the company’s stock, valued at approximately $2,135,239.80. This trade represents a 15.34% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Paramjeet K. Randhawa acquired 3,050 shares of the company’s stock in a transaction dated Wednesday, March 4th. The shares were acquired at an average price of $14.78 per share, for a total transaction of $45,079.00. Following the completion of the purchase, the director owned 19,560 shares of the company’s stock, valued at approximately $289,096.80. This represents a 18.47% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have purchased 117,015 shares of company stock worth $1,749,620. 1.80% of the stock is owned by corporate insiders.

Key Hercules Capital News

Here are the key news stories impacting Hercules Capital this week:

• Positive Sentiment: KBW published a Buy on HTGC, reinforcing buy‑side sentiment and providing a near‑term catalyst for investors focused on analyst support. KBW Buy
• Positive Sentiment: Keefe, Bruyette & Woods trimmed its price target to $18.00 but kept an “outperform” rating, signaling continued upside from some sell‑side analysts even as they moderate expectations. This helps explain some buying despite legal headlines. KBW PT Lowered
• Neutral Sentiment: Recent coverage in Yahoo Finance and Zacks highlights that Hercules’ Average Brokerage Recommendation reads as a “Buy,” but these meta pieces caution that consensus ratings can be over‑optimistic and should be weighed with fundamental and risk developments. Yahoo Finance ABR Zacks ABR
• Negative Sentiment: Multiple securities‑class‑action filings and broad law‑firm solicitations were announced (Hagens Berman, Faruqi & Faruqi, Pomerantz, Rosen, Bragar, Glancy, Schall, etc.), alleging misstatements and urging investors to seek lead‑plaintiff roles — a sustained flow of litigation notices that increases legal and reputational risk and can pressure the stock. Representative notice: Hagens Berman / GlobeNewswire. Hagens Berman Alert
• Negative Sentiment: Allegations in the underlying investigative report include claims that Hercules copied deal sourcing (Google Ventures), misstated valuations/marks, and concealed concentration in software‑related debt and PIK structures — these specific accusations (if pursued by plaintiffs or regulators) could materially affect portfolio valuation assumptions. Hagens Berman Allegations
• Negative Sentiment: Several firms are publicizing the May 19, 2026 lead‑plaintiff deadline — the flurry of reminders (Faruqi, Rosen, Pomerantz, Bragar, Schall, Glancy) keeps legal headlines in the news cycle and may amplify near‑term volatility. Example reminder: Faruqi & Faruqi. Faruqi Deadline

Analyst Ratings Changes

HTGC has been the topic of several recent analyst reports. Wells Fargo & Company reduced their price target on shares of Hercules Capital from $18.00 to $17.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Wall Street Zen cut shares of Hercules Capital from a “buy” rating to a “hold” rating in a research report on Saturday, December 20th. Piper Sandler dropped their target price on shares of Hercules Capital from $17.50 to $16.50 and set a “neutral” rating on the stock in a research note on Tuesday, April 7th. UBS Group reduced their target price on shares of Hercules Capital from $19.50 to $15.00 and set a “neutral” rating on the stock in a research report on Friday, March 13th. Finally, Keefe, Bruyette & Woods decreased their price target on shares of Hercules Capital from $19.00 to $18.00 and set an “outperform” rating for the company in a research note on Thursday. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $18.38.

Hercules Capital Price Performance

HTGC opened at $15.95 on Friday. The company has a market capitalization of $2.93 billion, a price-to-earnings ratio of 8.71 and a beta of 0.83. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 1.03. Hercules Capital, Inc. has a 12-month low of $13.70 and a 12-month high of $19.67. The business’s fifty day simple moving average is $15.01 and its 200-day simple moving average is $17.07.

Hercules Capital (NYSE:HTGC) last released its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.48 earnings per share for the quarter, meeting the consensus estimate of $0.48. Hercules Capital had a return on equity of 15.97% and a net margin of 63.80%.The firm had revenue of $133.25 million during the quarter, compared to the consensus estimate of $141.57 million. During the same period in the previous year, the company posted $0.49 earnings per share. On average, equities research analysts anticipate that Hercules Capital, Inc. will post 1.96 earnings per share for the current fiscal year.

Hercules Capital Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 4th. Stockholders of record on Wednesday, February 25th were issued a $0.07 dividend. The ex-dividend date was Wednesday, February 25th. This represents a $0.28 annualized dividend and a dividend yield of 1.8%. Hercules Capital’s payout ratio is currently 87.43%.

Hercules Capital Company Profile

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company’s investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.